Literature DB >> 7748562

Semaphorin III can function as a selective chemorepellent to pattern sensory projections in the spinal cord.

E K Messersmith1, E D Leonardo, C J Shatz, M Tessier-Lavigne, C S Goodman, A L Kolodkin.   

Abstract

Distinct classes of primary sensory neurons in dorsal root ganglia subserve different sensory modalities, terminate in different dorsoventral locations in the spinal cord, and display different neurotrophin response profiles. Large diameter muscle afferents that terminate in the ventral spinal cord are NT-3 responsive, whereas small diameter afferents subserving pain and temperature are NGF responsive and terminate in the dorsal spinal cord. Previous in vitro studies showed that the developing ventral spinal cord secretes a diffusible factor that inhibits the growth of sensory axons. Here we show that this factor repels NGF-responsive axons but has little effect on NT-3-responsive axons. We also provide evidence implicating semaphorin III/collapsin, a diffusible guidance molecule expressed by ventral spinal cord cells, in mediating this effect. These results suggest that semaphorin III functions to pattern sensory projections by selectively repelling axons that normally terminate dorsally.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7748562     DOI: 10.1016/0896-6273(95)90333-x

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  99 in total

1.  F-spondin is a contact-repellent molecule for embryonic motor neurons.

Authors:  V Tzarfati-Majar; T Burstyn-Cohen; A Klar
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

2.  Morphology and growth patterns of developing thalamocortical axons.

Authors:  I Skaliora; R Adams; C Blakemore
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

3.  Spatial distributions of guidance molecules regulate chemorepulsion and chemoattraction of growth cones.

Authors:  D Bagnard; N Thomasset; M Lohrum; A W Püschel; J Bolz
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

4.  Embryonic expression and extracellular secretion of Xenopus slit.

Authors:  J H Chen; W Wu; H S Li; T Fagaly; L Zhou; J Y Wu; Y Rao
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

5.  Diversity and specificity of actions of Slit2 proteolytic fragments in axon guidance.

Authors:  K T Nguyen Ba-Charvet; K Brose; L Ma; K H Wang; V Marillat; C Sotelo; M Tessier-Lavigne; A Chédotal
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

6.  Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2.

Authors:  Toshihiko Toyofuku; Hong Zhang; Atsushi Kumanogoh; Noriko Takegahara; Fumikazu Suto; Junko Kamei; Kazuhiro Aoki; Masanori Yabuki; Masatsugu Hori; Hajime Fujisawa; Hitoshi Kikutani
Journal:  Genes Dev       Date:  2004-02-20       Impact factor: 11.361

7.  Adenoviral vector-mediated expression of B-50/GAP-43 induces alterations in the membrane organization of olfactory axon terminals in vivo.

Authors:  A J Holtmaat; W T Hermens; M A Sonnemans; R J Giger; F W Van Leeuwen; M G Kaplitt; A B Oestreicher; W H Gispen; J Verhaagen
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

Review 8.  Regulation of dendritic development by semaphorin 3A through novel intracellular remote signaling.

Authors:  Yoshio Goshima; Naoya Yamashita; Fumio Nakamura; Yukio Sasaki
Journal:  Cell Adh Migr       Date:  2016-07-08       Impact factor: 3.405

9.  Semaphorin 3A elicits stage-dependent collapse, turning, and branching in Xenopus retinal growth cones.

Authors:  D S Campbell; A G Regan; J S Lopez; D Tannahill; W A Harris; C E Holt
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

10.  Upregulation of Semaphorin 3A and the associated biochemical and cellular events in a rat model of retinal detachment.

Authors:  Olga Klebanov; Anat Nitzan; Dorit Raz; Ari Barzilai; Arieh S Solomon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-25       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.